Clinical Trial 9979

Pembroke Pines, Fl 33024

Study Summary:

A phase III, multicenter, international, randomized, parallel group, double blind cardiovascular safety study of BI 100773 (10mg and 25mg administered orally once daily) compared to usual care in Type 2 diabetes patients with increased cardiovascular risk.

Qualified Participants Must:

• Be at least 18 years of age
• Be diagnosed with Type 2 diabetes
• Be able to provide medical records

Qualified Participants May Receive:

Study medication, study-related medical care, and may receive compensation.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.